The global Cancer Chemotherapy Associated Nausea and Vomiting (CINV) therapeutics market is estimated to be valued at US$3,071.1 million in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cancer chemotherapy often leads to side effects such as nausea and vomiting, which significantly impact the quality ... Read more
One of the most common and distressing side effects experienced by cancer patients undergoing chemotherapy is nausea and vomiting. Chemotherapy drugs work by targeting fast-growing cells like cancer, but they can also affect healthy cells in the gastrointestinal tract that are regularly replaced, causing nausea and vomiting. Until recent decades, nausea and vomiting associated with chemotherapy was a major challenge with few ... Read more
